Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
Clin Exp Hypertens
; 43(8): 730-741, 2021 Nov 17.
Article
in En
| MEDLINE
| ID: mdl-34425059
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
Hyperuricemia
/
Gout
/
Hypertension
Type of study:
Guideline
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Clin Exp Hypertens
Year:
2021
Document type:
Article
Affiliation country: